Swedish Orphan Biovitrum (United States)

Recent papers from Swedish Orphan Biovitrum (United States)

1. ATMP development and market access in Europe and the United States: why scientific innovation alone no longer winsCell and Gene Therapy Insights · 2026
2. Comparative Study of Bacteriophage Pharmacokinetics by Different Enteral Administration RoutesMethods and Protocols · 2026
3. ‘…completely exhausted and weak, really drained.’: a multinational qualitative interview study of healthcare provider, patient, and caregiver experiences of C3 glomerulopathy and primary (idiopathic) immune complex membranoproliferative glomerulonephritis diagnosis, burden and managementFrontiers in Nephrology · 2026
4. Pregnancy-Dependent Cardioprotection via GPER Activation in Dahl Salt-Sensitive Rats with Superimposed PreeclampsiaAJP Heart and Circulatory Physiology · 2025
5. Characterization of Solid-State Complexities in Pharmaceutical Materials via Stimulated Raman Scattering MicroscopyAnalytical Chemistry · 2025
6. The costs of treating bleeding episodes in patients with immune thrombocytopaenia in the United KingdomHematology · 2025
7. Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortalitySHILAP Revista de lepidopterología · 2024
8. P084 Gout symptom improvements and patient outcomes with SEL-212 in gout refractory to conventional therapy: DISSOLVE I & II phase 3, double-blind, placebo-controlled clinical trialsLara D. Veeken · 2024
9. Ovariectomy-Induced Arterial Stiffening Differs From Vascular Aging and Is Reversed by GPER ActivationHypertension · 2024
10. Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panelHaemophilia · 2024
11. The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal SyndromeKidney360 · 2023
12. Efficacy and safety of emapalumab in macrophage activation syndromeAnnals of the Rheumatic Diseases · 2023
13. Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trialHaemophilia · 2022
14. Effectiveness and Safety of Palivizumab for the Prevention of Serious Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus: A Systematic ReviewAmerican Journal of Perinatology · 2022
15. Phase 2 study of avatrombopag in Japanese patients with chronic liver disease and thrombocytopeniaHepatology Research · 2022
16. rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B: Post hoc analysis of B‐LONG using haemophilia‐specific quality of life questionnairesHaemophilia · 2021
17. Increasing Rates of RSV Hospitalization among Preterm Infants: A Decade of DataAmerican Journal of Perinatology · 2021
18. Process intensification to produce a difficult‐to‐express therapeutic enzyme by high cell density perfusion or enhanced fed‐batchBiotechnology and Bioengineering · 2021
19. Constitutive activation of WASp leads to abnormal cytotoxic cells with increased granzyme B and degranulation response to target cellsJCI Insight · 2021
20. An integrated continuous downstream process with real-time control: A case study with periodic countercurrent chromatography and continuous virus inactivation2020